The Catholic Leukemia and Lymphoma Institute is composed of leading medical professionals from Korea’s largest specialized hematologic cancer treatment center. The Institute continuously conducts basic and clinical research, with a particular focus on myelodysplastic syndromes and secondary acute myeloid leukemia. Through these errors, it has established well-defined disease cohorts encompassing extensive clinical data and biospecimens, and built robust research networks to advance collaborative studies.